1. Anti-infection NF-κB Metabolic Enzyme/Protease Immunology/Inflammation Autophagy
  2. Parasite Reactive Oxygen Species (ROS) Autophagy
  3. Antileishmanial agent-43

Antileishmanial agent-43 is a 3,4,5‑trisubstituted isoxazole with selective antileishmanial activity. Antileishmanial agent-43 shows IC50 values of 12.7 μM against Leishmania amazonensis promastigotes and 0.96 μM against intracellular amastigotes. Antileishmanial agent-43 induces ROS elevation, oxidative stress and mitochondrial dysfunction, resulting in lipid peroxidation, mitochondrial depolarization and ATP imbalance. Antileishmanial agent-43 causes cell shrinkage, phosphatidylserine externalization, plasma membrane permeabilization, and promotes autophagy. Antileishmanial agent-43 can be used for the research of leishmaniasis.

For research use only. We do not sell to patients.

Antileishmanial agent-43

Antileishmanial agent-43 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Antileishmanial agent-43 is a 3,4,5‑trisubstituted isoxazole with selective antileishmanial activity. Antileishmanial agent-43 shows IC50 values of 12.7 μM against Leishmania amazonensis promastigotes and 0.96 μM against intracellular amastigotes. Antileishmanial agent-43 induces ROS elevation, oxidative stress and mitochondrial dysfunction, resulting in lipid peroxidation, mitochondrial depolarization and ATP imbalance. Antileishmanial agent-43 causes cell shrinkage, phosphatidylserine externalization, plasma membrane permeabilization, and promotes autophagy. Antileishmanial agent-43 can be used for the research of leishmaniasis[1].

IC50 & Target[1]

Leishmania

 

In Vitro

Antileishmanial agent-43 (compound 4) (1-100 μM; 72 h) inhibits proliferation of Leishmania amazonensis promastigotes (IC50 = 12.7 μM)[1].
Antileishmanial agent-43 (0.1-100 μM; 48 h) suppresses growth of Leishmania amazonensis intracellular amastigotes (IC50 = 0.96 μM)[1].
Antileishmanial agent-43 (10-1000 μM; 48 h) exhibits low cytotoxicity against J774A.1 macrophages (CC50 = 196.1 μM) and L929 fibroblasts (CC50 = 232.1 μM)[1].
Antileishmanial agent-43 (12.7 μM, 25.4 μM for promastigotes; 0.96 μM, 1.92 μM for amastigotes; 24 h) elevates ROS and nitric oxide levels, induces lipid peroxidation, triggers mitochondrial depolarization, disturbs ATP homeostasis, causes cell shrinkage, phosphatidylserine externalization, plasma membrane permeabilization, and promotes autophagic vacuole and acidic compartment formation in Leishmania amazonensis promastigotes and amastigotes[1].
Antileishmanial agent-43 (12.7 μM, 25.4 μM for promastigotes; 0.96 μM, 1.92 μM for amastigotes; 72 h for promastigotes, 48 h for amastigotes) induces morphological and ultrastructural alterations in Leishmania amazonensis promastigotes and intracellular amastigotes[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Apoptosis Analysis[1]

Cell Line: Leishmania amazonensis promastigotes and intracellular amastigotes
Concentration: 12.7 μM, 25.4 μM (promastigotes); 0.96 μM, 1.92 μM (amastigotes)
Incubation Time: 24 h
Result: Induced apoptosis-like death, including phosphatidylserine externalization, cell shrinkage, and plasma membrane permeabilization in both promastigotes and amastigotes.

Cell Autophagy Assay[1]

Cell Line: Leishmania amazonensis promastigotes and intracellular amastigotes
Concentration: 12.7 μM, 25.4 μM (promastigotes); 0.96 μM, 1.92 μM (amastigotes)
Incubation Time: 24 h
Result: Promoted the formation of autophagic vacuoles and acidic compartments in both promastigotes and amastigotes.

Immunofluorescence[1]

Cell Line: Leishmania amazonensis promastigotes and intracellular amastigotes
Concentration: 12.7 μM, 25.4 μM (promastigotes); 0.96 μM, 1.92 μM (amastigotes)
Incubation Time: 24 h
Result: Detected elevated ROS and nitric oxide levels, as well as mitochondrial depolarization in treated parasites via fluorescence-based methods.
Molecular Weight

460.42

Formula

C23H17FN6O4

SMILES

O=C(C1=NOC(C2=CC=C([N+]([O-])=O)C=C2)=C1CNC3=CC=C(F)C=C3)N/N=C/C4=NC=CC=C4

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Antileishmanial agent-43
Cat. No.:
HY-183621
Quantity:
MCE Japan Authorized Agent: